Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Iran Stockpile 16x Higher than Deal Limit 

The 2015 Iran Nuclear Deal sets a limit of just over 200…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Religion Professors: Evangelical Christians Are White Racists 

A recent panel of professors at the University of Virginia…
Read more

PM Vows to Counter Iran’s Nuclear Ambitions

Benjamin Netanyahu has made it clear that he would risk his…
Read more